Fixed-dose combination of antiretroviral agents for the treatment of adult and adolescent patients ≥12 years (≥35kg) with HIV-1. It is used as part of a combination treatment regimen. Due to its composition, it causes less bone and renal involvement.
Drivelea
It is a fixed dose combination drug indicated for VIH positive patients and HLA-B*5701 negative patients, without hepatitis B virus.
Benjor
Tenofovir
Antiretroviral to treat HIV-caused infection, associated with other antivirals.
Simplir
Fixed combination of antiretroviral, indicated to treat HIV-caused infection.
Remivir
Fixed combination of antiretrovirals, nucleoside inhibitors of viral transcriptase Indicated to treat HIV-caused infection or for pre-exposure prophylaxis.
Nevirapina Elea
Antiretroviral to treat HIV-caused infection.
Lisotyr
Fixed combination of analogous antiretroviral, nucleoside reverse transcriptase inhibitor, indicated to treat HIV-caused infection.
Damaris
Fixed combination of analogous antiretrovirals, nucleoside reverse transcriptase, indicated to treat HIV-caused infection.
3-Tc/Azt Elea
Fixed combination of analogous antiretrovirals, nucleoside reverse transcriptase, indicated to treat HIV-caused infection.
